{
    "nctId": "NCT04166240",
    "briefTitle": "Measuring and Improving the Safety of Test Result Follow-Up",
    "officialTitle": "Measuring and Improving the Safety of Test Result Follow-Up",
    "overallStatus": "COMPLETED",
    "conditions": "Lung Cancer, Breast Cancer, Colon Cancer, Bladder Cancer, Hepatocellular Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "HEALTH_SERVICES_RESEARCH",
    "enrollmentCount": 46,
    "primaryOutcomeMeasure": "Trigger Outcome",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Medical records identified via CDW which fall under the EPRP measures (Fecal Occult Blood Test FOBT)/Fecal Immunohistochemical Test (FIT), Hepatitis C Virus (HCV), Mammogram, alpha feto protein (AFP), dual energy x-ray absorptiometry (DEXA) Scan, Pap/ human papillomavirus (HPV), Chest X-ray, and Chest CT)\n* Medical records containing clinical findings suspicious for breast cancer, lung cancer, bladder cancer, hepatocellular carcinoma, and colorectal cancer (CRC)\n\nExclusion Criteria:\n\n* Medical records that don't contain any tests, procedures, or appointments that need to be followed up on",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}